1
|
Yu C, Liu Y, Chan JTH, Tong J, Li Z, Shi M, Davani D, Parsons M, Khan S, Zhan W, Kyu S, Grunebaum E, Campisi P, Propst EJ, Jaye DL, Trudel S, Moran MF, Ostrowski M, Herrin BR, Lee FEH, Sanz I, Cooper MD, Ehrhardt GR. Identification of human plasma cells with a lamprey monoclonal antibody. JCI Insight 2016; 1:84738. [PMID: 27152361 DOI: 10.1172/jci.insight.84738] [Citation(s) in RCA: 24] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/18/2023] Open
Abstract
Ab-producing plasma cells (PCs) serve as key participants in countering pathogenic challenges as well as being contributors to autoimmune and malignant disorders. Thus far, only a limited number of PC-specific markers have been identified. The characterization of the unique variable lymphocyte receptor (VLR) Abs that are made by evolutionarily distant jawless vertebrates prompted us to investigate whether VLR Abs could detect novel PC antigens that have not been recognized by conventional Abs. Here, we describe a monoclonal lamprey Ab, VLRB MM3, that was raised against primary multiple myeloma cells. VLRB MM3 recognizes a unique epitope of the CD38 ectoenzyme that is present on plasmablasts and PCs from healthy individuals and on most, but not all, multiple myelomas. Binding by the VLRB MM3 Ab coincides with CD38 dimerization and NAD glycohydrolase activity. Our data demonstrate that the lamprey VLRB MM3 Ab is a unique reagent for the identification of plasmablasts and PCs, with potential applications in the diagnosis and therapeutic intervention of PC or autoimmune disorders.
Collapse
Affiliation(s)
- Cuiling Yu
- Department of Pathology and Laboratory Medicine, Emory Vaccine Center and the Winship Cancer Institute, Emory University Hospital, Atlanta, Georgia, USA
| | - Yanling Liu
- Department of Immunology, University of Toronto, Toronto, Ontario, Canada
| | - Justin Tze Ho Chan
- Department of Immunology, University of Toronto, Toronto, Ontario, Canada
| | - Jiefei Tong
- Department of Molecular Genetics, Hospital for Sick Children, Toronto, Ontario, Canada
| | - Zhihua Li
- Department of Medical Oncology and Haematology, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada
| | - Mengyao Shi
- Department of Immunology, University of Toronto, Toronto, Ontario, Canada
| | - Dariush Davani
- Department of Immunology, University of Toronto, Toronto, Ontario, Canada
| | - Marion Parsons
- Department of Immunology, University of Toronto, Toronto, Ontario, Canada
| | - Srijit Khan
- Department of Immunology, University of Toronto, Toronto, Ontario, Canada
| | - Wei Zhan
- Department of Immunology, University of Toronto, Toronto, Ontario, Canada
| | - Shuya Kyu
- Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, Emory University Hospital, Atlanta, Georgia, USA
| | | | - Paolo Campisi
- Department of Otolaryngology - Head and Neck Surgery, Hospital for Sick Children and University of Toronto, Toronto, Ontario, Canada
| | - Evan J Propst
- Department of Otolaryngology - Head and Neck Surgery, Hospital for Sick Children and University of Toronto, Toronto, Ontario, Canada
| | - David L Jaye
- Department of Pathology and Laboratory Medicine, Emory Vaccine Center and the Winship Cancer Institute, Emory University Hospital, Atlanta, Georgia, USA
| | - Suzanne Trudel
- Department of Medical Oncology and Haematology, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada
| | - Michael F Moran
- Department of Molecular Genetics, Hospital for Sick Children, Toronto, Ontario, Canada
| | - Mario Ostrowski
- Department of Immunology, University of Toronto, Toronto, Ontario, Canada
| | - Brantley R Herrin
- Department of Pathology and Laboratory Medicine, Emory Vaccine Center and the Winship Cancer Institute, Emory University Hospital, Atlanta, Georgia, USA
| | - F Eun-Hyung Lee
- Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, Emory University Hospital, Atlanta, Georgia, USA
| | - Ignacio Sanz
- Division of Rheumatology, Lowance Center, Emory University Hospital, Atlanta, Georgia, USA
| | - Max D Cooper
- Department of Pathology and Laboratory Medicine, Emory Vaccine Center and the Winship Cancer Institute, Emory University Hospital, Atlanta, Georgia, USA
| | - Götz Ra Ehrhardt
- Department of Immunology, University of Toronto, Toronto, Ontario, Canada
| |
Collapse
|
2
|
Etich J, Bergmeier V, Frie C, Kreft S, Bengestrate L, Eming S, Mauch C, Eckes B, Ulus H, Lund FE, Rappl G, Abken H, Paulsson M, Brachvogel B. PECAM1(+)/Sca1(+)/CD38(+) vascular cells transform into myofibroblast-like cells in skin wound repair. PLoS One 2013; 8:e53262. [PMID: 23308177 PMCID: PMC3537615 DOI: 10.1371/journal.pone.0053262] [Citation(s) in RCA: 20] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/31/2012] [Accepted: 11/27/2012] [Indexed: 12/26/2022] Open
Abstract
Skin injury induces the formation of new blood vessels by activating the vasculature in order to restore tissue homeostasis. Vascular cells may also differentiate into matrix-secreting contractile myofibroblasts to promote wound closure. Here, we characterize a PECAM1+/Sca1+ vascular cell population in mouse skin, which is highly enriched in wounds at the peak of neoangiogenesis and myofibroblast formation. These cells express endothelial and perivascular markers and present the receptor CD38 on their surface. PECAM1+/Sca1+/CD38+ cells proliferate upon wounding and could give rise to α-SMA+ myofibroblast-like cells. CD38 stimulation in immunodeficient mice reduced the wound size at the peak of neoangiogenesis and myofibroblast formation. In humans a corresponding cell population was identified, which was enriched in sprouting vessels of basal cell carcinoma biopsies. The results indicate that PECAM1+/Sca1+/CD38+ vascular cells could proliferate and differentiate into myofibroblast-like cells in wound repair. Moreover, CD38 signaling modulates PECAM1+/Sca1+/CD38+ cell activation in the healing process implying CD38 as a target for anti-angiogenic therapies in human basal cell carcinoma.
Collapse
Affiliation(s)
- Julia Etich
- Center for Biochemistry, Medical Faculty, University of Cologne, Cologne, North Rhine-Westphalia, Germany
| | - Vera Bergmeier
- Center for Biochemistry, Medical Faculty, University of Cologne, Cologne, North Rhine-Westphalia, Germany
| | - Christian Frie
- Center for Biochemistry, Medical Faculty, University of Cologne, Cologne, North Rhine-Westphalia, Germany
| | - Sandra Kreft
- Center for Biochemistry, Medical Faculty, University of Cologne, Cologne, North Rhine-Westphalia, Germany
| | - Lena Bengestrate
- Center for Biochemistry, Medical Faculty, University of Cologne, Cologne, North Rhine-Westphalia, Germany
| | - Sabine Eming
- Center for Molecular Medicine Cologne (CMMC), Medical Faculty, University of Cologne, Cologne, North Rhine-Westphalia, Germany
- Department of Dermatology, University of Cologne, Cologne, North Rhine-Westphalia, Germany
| | - Cornelia Mauch
- Department of Dermatology, University of Cologne, Cologne, North Rhine-Westphalia, Germany
| | - Beate Eckes
- Department of Dermatology, University of Cologne, Cologne, North Rhine-Westphalia, Germany
| | - Hikmet Ulus
- Clinic for Paediatric Surgery, Cologne, North Rhine-Westphalia, Germany
| | - Frances E. Lund
- Department of Medicine, University of Rochester Medical Center, Rochester, New York, United States of America
| | - Gunter Rappl
- Center for Molecular Medicine Cologne (CMMC), Medical Faculty, University of Cologne, Cologne, North Rhine-Westphalia, Germany
- Tumorgenetics, Department I of Internal Medicine, Medical Faculty, University of Cologne, Cologne, North Rhine-Westphalia, Germany
| | - Hinrich Abken
- Center for Molecular Medicine Cologne (CMMC), Medical Faculty, University of Cologne, Cologne, North Rhine-Westphalia, Germany
- Tumorgenetics, Department I of Internal Medicine, Medical Faculty, University of Cologne, Cologne, North Rhine-Westphalia, Germany
| | - Mats Paulsson
- Center for Biochemistry, Medical Faculty, University of Cologne, Cologne, North Rhine-Westphalia, Germany
- Center for Molecular Medicine Cologne (CMMC), Medical Faculty, University of Cologne, Cologne, North Rhine-Westphalia, Germany
- Cologne Excellence Cluster on Cellular Stress Responses in Aging - Associated Diseases (CECAD), Cologne, North Rhine-Westphalia, Germany
| | - Bent Brachvogel
- Center for Biochemistry, Medical Faculty, University of Cologne, Cologne, North Rhine-Westphalia, Germany
- Center for Molecular Medicine Cologne (CMMC), Medical Faculty, University of Cologne, Cologne, North Rhine-Westphalia, Germany
- * E-mail:
| |
Collapse
|
3
|
Jover E, Tawk MY, Laventie BJ, Poulain B, Prévost G. Staphylococcal leukotoxins trigger free intracellular Ca(2+) rise in neurones, signalling through acidic stores and activation of store-operated channels. Cell Microbiol 2012; 15:742-58. [PMID: 23152983 PMCID: PMC3654557 DOI: 10.1111/cmi.12069] [Citation(s) in RCA: 18] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/21/2012] [Revised: 10/18/2012] [Accepted: 11/06/2012] [Indexed: 12/31/2022]
Abstract
Headache, muscle aches and chest pain of mild to medium intensity are among the most common clinical symptoms in moderate Staphylococcus aureus infections, with severe infections usually associated with worsening pain symptoms. These nociceptive responses of the body raise the question of how bacterial infection impinges on the nervous system. Does S. aureus, or its released virulence factors, act directly on neurones? To address this issue, we evaluated the potential effects on neurones of certain bi-component leukotoxins, which are virulent factors released by the bacterium. The activity of four different leukotoxins was verified by measuring the release of glutamate from rat cerebellar granular neurones. The bi-component γ-haemolysin HlgC/HlgB was the most potent leukotoxin, initiating transient rises in intracellular Ca2+ concentration in cerebellar neurones and in primary sensory neurones from dorsal root ganglia, as probed with the Fura-2 Ca2+ indicator dye. Using pharmacological antagonists of receptors and Ca2+ channels, the variations in intracellular Ca2+ concentration were found independent of the activation of voltage-operatedCa2+ channels or glutamate receptors. Drugs targeting Sarco-Endoplasmic Reticulum Ca2+-ATPase (SERCA) or H+-ATPase and antagonists of the store-operated Ca2+ entry complex blunted, or significantly reduced, the leukotoxin-induced elevation in intracellular Ca2+. Moreover, activation of the ADP-ribosyl cyclase CD38 was also required to initiate the release of Ca2+ from acidic stores. These findings suggest that, prior to forming a pore at the plasma membrane, leukotoxin HlgC/HlgB triggers a multistep process which initiates the release of Ca2+ from lysosomes, modifies the steady-state level of reticular Ca2+ stores and finally activates the Store-Operated Calcium Entry complex.
Collapse
Affiliation(s)
- Emmanuel Jover
- INCI - UPR-CNRS 3212, Neurotransmission et sécrétion neuroendocrine, 5, rue Blaise Pascal, F- 67084 Strasbourg cedex, France. jover@inci-cnrs
| | | | | | | | | |
Collapse
|
4
|
Hara-Yokoyama M, Kukimoto-Niino M, Terasawa K, Harumiya S, Podyma-Inoue KA, Hino N, Sakamoto K, Itoh S, Hashii N, Hiruta Y, Kawasaki N, Mishima-Tsumagari C, Kaitsu Y, Matsumoto T, Wakiyama M, Shirouzu M, Kasama T, Takayanagi H, Utsunomiya-Tate N, Takatsu K, Katada T, Hirabayashi Y, Yokoyama S, Yanagishita M. Tetrameric interaction of the ectoenzyme CD38 on the cell surface enables its catalytic and raft-association activities. Structure 2012; 20:1585-95. [PMID: 22863568 DOI: 10.1016/j.str.2012.06.017] [Citation(s) in RCA: 23] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/16/2012] [Revised: 06/22/2012] [Accepted: 06/30/2012] [Indexed: 01/22/2023]
Abstract
The leukocyte cell-surface antigen CD38 is the major nicotinamide adenide dinucleotide glycohydrolase in mammals, and its ectoenzyme activity is involved in calcium mobilization. CD38 is also a raft-dependent signaling molecule. CD38 forms a tetramer on the cell surface, but the structural basis and the functional significance of tetramerization have remained unexplored. We identified the interfaces contributing to the homophilic interaction of mouse CD38 by site-specific crosslinking on the cell surface with an expanded genetic code, based on a crystallographic analysis. A combination of the three interfaces enables CD38 to tetramerize: one interface involving the juxtamembrane α-helix is responsible for the formation of the core dimer, which is further dimerized via the other two interfaces. This dimerization of dimers is required for the catalytic activity and the localization of CD38 in membrane rafts. The glycosylation prevents further self-association of the tetramer. Accordingly, the tetrameric interaction underlies the multifaceted actions of CD38.
Collapse
Affiliation(s)
- Miki Hara-Yokoyama
- Section of Biochemistry, Tokyo Medical and Dental University, Tokyo 113-8549, Japan.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
5
|
Mukai T, Wakiyama M, Sakamoto K, Yokoyama S. Genetic encoding of non-natural amino acids in Drosophila melanogaster Schneider 2 cells. Protein Sci 2010; 19:440-8. [PMID: 20052681 DOI: 10.1002/pro.322] [Citation(s) in RCA: 33] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
Abstract
Insect cells are useful for the high-yield production of recombinant proteins including chemokines and membrane proteins. In this study, we developed an insect cell-based system for incorporating non-natural amino acids into proteins at specific sites. Three types of promoter systems were constructed, and their efficiencies were compared for the expression of the prokaryotic amber suppressor tRNA(Tyr) in Drosophila melanogaster Schneider 2 cells. When paired with a variant of Escherichia coli tyrosyl-tRNA synthetase specific for 3-iodo-L-tyrosine, the suppressor tRNA transcribed from the U6 promoter most efficiently incorporated the amino acid into proteins in the cells. The transient and stable introductions of these prokaryotic molecules into the insect cells were then compared in terms of the yield of proteins containing non-natural amino acids, and the "transient" method generated a sevenfold higher yield. By this method, 4-azido-L-phenylalanine was incorporated into human interleukin-8 at a specific site. The yield of the azido-containing IL-8 was 1 microg/1 mL cell culture, and the recombinant protein was successfully labeled with a fluorescent probe by the Staudinger-Bertozzi reaction.
Collapse
Affiliation(s)
- Takahito Mukai
- RIKEN Systems and Structural Biology Center, Tsurumi, Yokohama 230-0045, Japan
| | | | | | | |
Collapse
|
6
|
Liu Q, Graeff R, Kriksunov IA, Lam CMC, Lee HC, Hao Q. Conformational Closure of the Catalytic Site of Human CD38 Induced by Calcium. Biochemistry 2008; 47:13966-13973. [DOI: 10.1021/bi801642q] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/01/2023]
Affiliation(s)
- Qun Liu
- MacCHESS, Cornell High Energy Synchrotron Source, and School of Applied and Engineering Physics, Cornell University, Ithaca, New York 14853, Department of Pharmacology, University of Minnesota, Minneapolis, Minnesota 55455, and Department of Physiology, University of Hong Kong, Hong Kong, China
| | - Richard Graeff
- MacCHESS, Cornell High Energy Synchrotron Source, and School of Applied and Engineering Physics, Cornell University, Ithaca, New York 14853, Department of Pharmacology, University of Minnesota, Minneapolis, Minnesota 55455, and Department of Physiology, University of Hong Kong, Hong Kong, China
| | - Irina A. Kriksunov
- MacCHESS, Cornell High Energy Synchrotron Source, and School of Applied and Engineering Physics, Cornell University, Ithaca, New York 14853, Department of Pharmacology, University of Minnesota, Minneapolis, Minnesota 55455, and Department of Physiology, University of Hong Kong, Hong Kong, China
| | - Connie M. C. Lam
- MacCHESS, Cornell High Energy Synchrotron Source, and School of Applied and Engineering Physics, Cornell University, Ithaca, New York 14853, Department of Pharmacology, University of Minnesota, Minneapolis, Minnesota 55455, and Department of Physiology, University of Hong Kong, Hong Kong, China
| | - Hon Cheung Lee
- MacCHESS, Cornell High Energy Synchrotron Source, and School of Applied and Engineering Physics, Cornell University, Ithaca, New York 14853, Department of Pharmacology, University of Minnesota, Minneapolis, Minnesota 55455, and Department of Physiology, University of Hong Kong, Hong Kong, China
| | - Quan Hao
- MacCHESS, Cornell High Energy Synchrotron Source, and School of Applied and Engineering Physics, Cornell University, Ithaca, New York 14853, Department of Pharmacology, University of Minnesota, Minneapolis, Minnesota 55455, and Department of Physiology, University of Hong Kong, Hong Kong, China
| |
Collapse
|